RPRX

Royalty Pharma
D

RPRX

Arincen67/100B
67.290
USD
-0.26
(-0.38%)
Post Trading·68.800USD+1.510(+2.24%)
Last updated: · Delayed 15 min
Fair value63.11Plus+7%48Price 67.2994
Q4 FY2026 · Earnings report
EPS estimate 1.53Revenue estimate 960.74M
OverviewFinancialsForecastEarningsDividendsCompany

Royalty Pharma market cap

Royalty Pharma's market cap is 29.96B USD: 445,265,805 shares outstanding at today's price of 67.29.

Today
29.96B
Average, 5 years
16.40B
Low, 5 years
10.82B
High, 5 years
30.06B

Market cap = price × shares outstanding = 67.29 × 445.27M = 29.96B

Each day's closing price times the shares outstanding in the last 10-Q or 10-K filed by then (the quarter's basic share count, adjusted for splits); from the latest count on, the shares outstanding now.

Market cap by year and by quarter

Fiscal yearPeriod endingMarket cap
Today29.96B
FY202531 Dec 202516.69B
FY202431 Dec 202411.38B
FY202331 Dec 202312.57B
FY202231 Dec 202217.31B
FY202131 Dec 202116.53B
FY202031 Dec 202019.43B
FY201931 Dec 201915.76B
FY201831 Dec 201815.76B
FY201731 Dec 201715.76B
FY201631 Dec 201627.01B
FY201531 Dec 201527.01B

See also:P/E ratio,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Royalty Pharma's market cap

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.